Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.45% | 201.80 | 1.2% | $542.05m | |
| GILD | Gilead Sciences, Inc. | -1.21% | 73.27 | 0.9% | $465.10m | |
| BIIB | Biogen Inc. | -2.95% | 320.41 | 1.3% | $380.15m | |
| CELG | Celgene Corporation | -0.65% | 82.41 | 1.2% | $337.48m | |
| ILMN | Illumina, Inc. | -2.60% | 313.10 | 3.5% | $332.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.36% | 389.83 | 2.6% | $235.91m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.79% | 175.69 | 1.9% | $230.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.53% | 125.89 | 2.0% | $220.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.30% | 134.22 | 16.4% | $169.84m | |
| A | Agilent Technologies, Inc. | -1.95% | 64.47 | 1.5% | $159.28m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.58% | 103.22 | 4.4% | $142.60m | |
| LGND | Ligand Pharmaceuticals Incorporated | -4.84% | 187.52 | 23.3% | $115.84m | |
| EXAS | Exact Sciences Corporation | -2.88% | 61.64 | 25.3% | $102.69m | |
| NKTR | Nektar Therapeutics | -2.76% | 48.19 | 5.6% | $101.86m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.24% | 112.01 | 5.1% | $98.21m |
Company Profile
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual. The Other segmeng provides products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and includes corporate services such as finance, human resources, legal and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake, UT.